Balyasny Asset Management »

Diamedica Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $136k 17k 7.96
2025-03-31 $96k 25k 3.79
2024-12-31 $79k 15k 5.43

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Tesla Motors Call Option (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr State Street Fin (XLF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vaneck Etf Trust Semiconductr Etf (SMH)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)

View all positions for Balyasny Asset Management

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Paragon Associates & Paragon Associates Ii Joint Venture
Millennium Management
Geode Capital Management
Vanguard Group
State Street Corporation
First Manhattan
Bleichroeder
Northern Trust
Advisor Group Holdings
LPL Financial
Citadel Advisors
Goldman Sachs Group
Bank of New York Mellon

View all funds holding Diamedica Therapeutics